ATXIAvenue Therapeutics, Inc.
Price Chart
Loading chart...
About Avenue Therapeutics, Inc. (ATXI)
Avenue Therapeutics, Inc. (ATXI) is a Biotechnology company headquartered in Bay Harbor Islands, FL, United States whose shares trade over-the-counter on the Pink tier.
Avenue Therapeutics is a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of neurologic diseases. The Company is advancing a diverse portfolio that includes first-in-class and best-in-class programs in a high-value neurologic landscape with significant unmet patient need.
ATXI key facts
- Ticker symbol
- ATXI
- Market tier
- Pink
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- Bay Harbor Islands, FL, United States
- Country of incorporation
- US
- Estimated market cap
- $787.7K (as of Apr 10, 2025)
- Shares outstanding
- 3,149,702
- Reporting standard
- U.S. Reporting: SEC Reporting
- Audit status
- Audited
- Fiscal year end
- 12/31
Explore more: Biotechnology stocks · Healthcare sector · Pink stocks · OTC stocks starting with A
Press Releases
Loading press releases...
Latest News
Loading news...
Key Statistics
Major Holders
Loading...
Loading modules...
AI-Powered Stock Analysis
Get a concise 600-word investment analysis for Avenue Therapeutics, Inc. (ATXI) prioritizing the most recent news and developments. Our AI focuses on today's breaking news first, then recent company developments, business updates, strategic initiatives, and current market positioning. Get the most relevant and current analysis available.
Still in beta - Please send feedback after generating your analysis to help us improve!
Smart investment analysis prioritizing breaking news, then recent company developments and strategic insights - completely free!
More Biotechnology Companies on OTC Markets
Investor Reviews
Investor Reviews (0)
Loading reviews...
Company Profile
Loading company profile data...
Contact Information
Social Media
Business Details
Stock Details
Loading modules...